https://canceradvocacy.org/wp-content/uploads/Brandon-Hertzendorf-Advocate-Spotlight-Blog-Banner.jpg
600
1200
Elleni
https://canceradvocacy.org/wp-content/uploads/CancerNation_Logo_Horiz_TwoColor.svg
Elleni2026-01-22 11:48:322026-01-22 11:49:53Research Made Survival Possible: Brandon Hertzendorf on Turning Experience into AdvocacyNCCS is now Cancer Nation. Find out more about our next chapter. Join Us
Health Equity
NCCS represents the millions of Americans who live with, through and beyond a cancer diagnosis. But the cancer experience is not the same for everyone. Gains in cancer survival due to advances in treatment and screening are not shared by all who are diagnosed with cancer.
Outcomes vary significantly based on a number of factors, including race/ethnicity, socioeconomic status, health insurance status, and geographic location. According to researchers from the American Cancer Society, a quarter of the approximately 600,000 annual cancer deaths in the United States could be prevented if everyone had access to the same prevention, screening, and treatment.
NCCS works on policy efforts to address health equity and reducing disparities in outcomes. The problem of health equity is complex, as some of the factors that lead to inequity are deeply rooted in social determinants of health and systemic and institutional barriers. Many of the policies that would improve access to care would contribute to reducing disparities. The Affordable Care Act (ACA), including its expansion of Medicaid, has reduced disparities in access to care and mortality rates, compared to states that chose not to expand Medicaid.
https://canceradvocacy.org/wp-content/uploads/Brandon-Hertzendorf-Advocate-Spotlight-Blog-Banner.jpg
600
1200
Elleni
https://canceradvocacy.org/wp-content/uploads/CancerNation_Logo_Horiz_TwoColor.svg
Elleni2026-01-22 11:48:322026-01-22 11:49:53Research Made Survival Possible: Brandon Hertzendorf on Turning Experience into Advocacy
The Meaning We Make: Laurel Braitman’s Path from Co-Survivor to Advocate

Cancer Nation Releases Survivorship Survey 2025 Results

Statement on Dr. Richard Pazdur Being Named FDA Center for Drug Evaluation and Research Director

Webinar – Navegando la terapia de células T con CAR: su camino hacia la recuperación

30+ Patient Orgs Urge Congress to Extend Health Care Tax Credits Immediately

Webinar: Navigating Communication on Clinical Trials in Oncology


